{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:27:46Z","timestamp":1768919266059,"version":"3.49.0"},"reference-count":20,"publisher":"BMJ","issue":"9","funder":[{"name":"Royal College of Ophthalmologist Ross Bursery"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>Background\/Aims<\/jats:title><jats:p>This study quantifies the threat to vision and the survival in patients presenting with peripheral ulcerative keratopathy (PUK) corneal perforation associated with rheumatoid arthritis (RA) in the UK.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>New cases of corneal perforation from PUK in patients with RA were prospectively collected from the UK via the British Ophthalmological Surveillance Unit from July 2012 to June 2014. An initial questionnaire collected data on presentation and the first 2\u2009weeks\u2019 management, and a follow-up questionnaire collected 1-year data on ocular morbidity and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>30 eyes of 28 patients were identified over 2\u2009years, estimating a UK incidence of 0.234\/million\/year. 20\/27 (74%) were female, with a median age of 68 years (range 41\u201384). The most common initial management was cyanoacrylate glue with a bandage contact lens, oral steroids, topical and oral antibiotics, and lubricants. Long-term management included corneal grafting in 12\/20 (60%) eyes of patients living at 1\u2009year. The 1-year all-cause mortality was 6\/25 (24%), which increased to 1\/2 (50%) if both eyes had perforated. In the remaining patients alive at 1-year follow-up, there was a 13\/20 (65%) poor visual outcome of less than or equal to counting fingers. 8\/25 (40%) patients had bilateral PUK, with 2\/25 (8%) having bilateral perforation. 5\/19 (26%) patients alive at 1-year follow-up were eligible for sight impairment registration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study highlights the serious ocular morbidity and high mortality associated with corneal perforation from PUK in patients with RA despite treatment. The mortality doubled if both eyes perforated, which should serve as a harbinger of impending serious medical problems.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-310671","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T17:16:59Z","timestamp":1513358219000},"page":"1298-1302","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit"],"prefix":"10.1136","volume":"102","author":[{"given":"Hannah Mary","family":"Timlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-1523","authenticated-orcid":false,"given":"Hildegard Nikki","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barny","family":"Foot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Koay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"2020050713020049000_102.9.1298.1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.12.1245"},{"key":"2020050713020049000_102.9.1298.2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7298026","article-title":"Peripheral ulcerative keratitis associated with autoimmune disease: pathogenesis and treatment","volume":"2017","author":"Cao","year":"2017","journal-title":"J Ophthalmol"},{"key":"2020050713020049000_102.9.1298.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390213"},{"key":"2020050713020049000_102.9.1298.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381114"},{"key":"2020050713020049000_102.9.1298.5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700233"},{"key":"2020050713020049000_102.9.1298.6","unstructured":"Office for National Statistics. UK population estimates 2013. 2014 http:\/\/webarchive.nationalarchives.gov.uk\/20160105160709\/http:\/\/www.ons.gov.uk\/ons\/rel\/pop-estimate\/population-estimates-for-uk-england-and-wales-scotland-and-northern-ireland\/2013\/sty-population-estimates.html"},{"key":"2020050713020049000_102.9.1298.7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2012.09.050","article-title":"Rheumatoid arthritis-associated corneal ulceration: mortality and graft survival","volume":"120","author":"Stylianides","year":"2013","journal-title":"Ophthalmology"},{"key":"2020050713020049000_102.9.1298.8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10654-016-0167-1","article-title":"Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study","volume":"31","author":"Movahedi","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2020050713020049000_102.9.1298.9","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000008"},{"key":"2020050713020049000_102.9.1298.10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/112067210601600602","article-title":"Rheumatoid keratolysis: a series of 40 eyes","volume":"16","author":"Malik","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"2020050713020049000_102.9.1298.11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatology"},{"key":"2020050713020049000_102.9.1298.12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.rhu.0000164819.23298.53","article-title":"Corneal melt in rheumatic disorders: effect of disease-modifying antirheumatic drugs on morbidity","volume":"11","author":"Saripalli","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"2020050713020049000_102.9.1298.13","doi-asserted-by":"publisher","DOI":"10.1159\/000063847"},{"key":"2020050713020049000_102.9.1298.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000151547.08113.d1"},{"key":"2020050713020049000_102.9.1298.15","doi-asserted-by":"crossref","unstructured":"Livny E , Mimouni M , Bahar I , et al . Corneal melting in rheumatoid arthritis patients treated with a tectonic reinforcing corneolimbal graft: an interventional case series. Int Ophthalmol 2017.doi:10.1007\/s10792-017-0545-z","DOI":"10.1007\/s10792-017-0545-z"},{"key":"2020050713020049000_102.9.1298.16","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.8.941"},{"key":"2020050713020049000_102.9.1298.17","unstructured":"Sheffield City Council. 2011 Census for sheffield. 2011 https:\/\/www.sheffield.gov.uk\/your-city-council\/sheffield-profile\/population-and-health\/2011-census.html"},{"key":"2020050713020049000_102.9.1298.18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0161-6420(95)30867-6","article-title":"The management of corneal perforations associated with rheumatoid arthritis. An analysis of 32 eyes","volume":"102","author":"Bernauer","year":"1995","journal-title":"Ophthalmology"},{"key":"2020050713020049000_102.9.1298.19","unstructured":"U.S. Census Bureau. Population census 2010. 2010 http:\/\/www.citypopulation.de\/php\/usa-virginia.php?adm2id=51590"},{"key":"2020050713020049000_102.9.1298.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.7.793"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:55:37Z","timestamp":1601110537000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,8,17]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310671"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310671","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}